Premium
Vera Therapeutics Inc (VERA)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injecti... Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -9.665 | -26.0336700337 | 37.125 | 37.22 | 27.46 | 496479 | 34.93388407 | CS |
| 4 | -5.57 | -16.8634574629 | 33.03 | 40.47 | 27.46 | 648021 | 35.64504167 | CS |
| 12 | -19.885 | -42.0002112155 | 47.345 | 51.27 | 27.46 | 612695 | 39.94433746 | CS |
| 26 | -10.92 | -28.4523189161 | 38.38 | 51.61 | 27.46 | 663925 | 41.58990799 | CS |
| 52 | -16.43 | -37.4344953292 | 43.89 | 51.61 | 27.46 | 740487 | 41.3051469 | CS |
| 156 | 9.1 | 49.5642701525 | 18.36 | 51.61 | 5.2 | 556888 | 27.17025003 | CS |
| 260 | 16.05 | 140.666082384 | 11.41 | 51.61 | 5.2 | 458378 | 26.95930582 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
